Common germline-somatic variant interactions in advanced urothelial cancer
The role of germline variation in human cancers is not fully understood. Here, the authors define the landscape of putative deleterious germline variants that abrogate tumor suppressor proteins in advanced urothelial cancer patients.
Main Authors: | Aram Vosoughi, Tuo Zhang, Kyrillus S. Shohdy, Panagiotis J. Vlachostergios, David C. Wilkes, Bhavneet Bhinder, Scott T. Tagawa, David M. Nanus, Ana M. Molina, Himisha Beltran, Cora N. Sternberg, Samaneh Motanagh, Brian D. Robinson, Jenny Xiang, Xiao Fan, Wendy K. Chung, Mark A. Rubin, Olivier Elemento, Andrea Sboner, Juan Miguel Mosquera, Bishoy M. Faltas |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2020-12-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-020-19971-8 |
Similar Items
-
Functional comparison of exome capture-based methods for transcriptomic profiling of formalin-fixed paraffin-embedded tumors
by: Kyrillus S. Shohdy, et al.
Published: (2021-08-01) -
Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling
by: Brian D. Robinson, et al.
Published: (2019-07-01) -
How Adequate is the Adequate Kidney Function for Clinical Trial Enrollment of Novel Anticancer Drugs?
by: Nehal Gamal, et al.
Published: (2020-12-01) -
Cornering metastases: therapeutic targeting of circulating tumor cells and stem cells.
by: Bishoy eFaltas
Published: (2012-07-01) -
Esterified Anabolic Androgen-Induced Liver Injury in a Hepatitis C Virus-Positive Patient: A CaseReport
by: Kyrillus S. Shohdy, et al.
Published: (2015-10-01)